New Delhi: Aerogen, an Ireland-based leader in acute-care aerosol drug delivery, has announced the opening of its India headquarters in the National Capital Territory (NCT) of Delhi. As per the company, the opening of the India headquarters represents a major investment in the APAC region and reinforces their long-term vision for India.
The new office in New Delhi will serve as the operational hub for a growing team of experts, including a country director, marketing professionals, commercial sales specialists, and clinical experts.
Starting with 14 team members, Aerogen plans to expand to 30 employees over the next five years to support its growth and market penetration. This strategic expansion underscores Aerogen’s commitment to supporting India’s growing healthcare sector by improving access to cutting-edge aerosol drug delivery solutions.
“With India’s large population and the increasing prevalence of respiratory diseases, our expansion is a crucial step in supporting the healthcare system in delivering superior patient care safely and effectively,” Hannah Yuill, Senior Commercial Director APAC, Aerogen said.
“This investment in India is a vital part of our strategy to expand across the APAC region and collaborate closely with healthcare professionals to improve respiratory treatment outcomes,” he added.
Aerogen’s presence in India is set to drive investment in research, partnerships, and training programs to ensure the widespread adoption of its advanced aerosol drug delivery technology, the company said in a release.
